Promoter hypermethylation and post-transcriptional mechanisms for reduced BRCA1 immunoreactivity in sporadic human breast cancers.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Japanese Journal of Clinical Oncology

• Publication date

  2002-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/JJCO/HYF020PMID 11956301
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Frequency of BRCA1 and BRCA2 germline mutations in Japanese breast cancer families

  2001cited by this paper
• BRCA1 Expression Status in Relation to DNA Methylation of the BRCA1 Promoter Region in Sporadic Breast Cancers

  2000cited by this paper
• Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors.

  2000cited by this paper
• Regulation of BRCA1 by protein degradation

  1999cited by this paper
• Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristics

  1999cited by this paper
• Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas

  1999influential reference
• Reduction of BRCA1 protein expression in Japanese sporadic breast carcinomas and its frequent loss in BRCA1-associated cases.

  1999cited by this paper
• CpG methylation within the 5′ regulatory region of the BRCA1 gene is tumor specific and includes a putative CREB binding site

  1998cited by this paper
• Down-regulation of BRCA1 in human sporadic breast cancer; analysis of DNA methylation patterns of the putative promoter region

  1998cited by this paper
• An evaluation of common breast cancer gene mutations in a population of Ashkenazi Jews.

  1998cited by this paper
• BRCA1 and BRCA2 Mutations in Ashkenazi Jewish Families with Breast and Ovarian Cancer

  1997cited by this paper
• Methylation of the BRCA1 gene in sporadic breast cancer.

  1997cited by this paper
• Complex Regulation of the BRCA1 Gene*

  1997cited by this paper
• A screening for BRCA1 mutations in breast and breast-ovarian cancer families from the Stockholm region.

  1997cited by this paper
• Detection of germline BRCA1 mutations in breast cancer patients by quantitative messenger RNA in situ hybridization.

  1996cited by this paper
• The Majority of 22 Dutch High-Risk Breast Cancer Families Are due to Either BRCA1 or BRCA2

  1996cited by this paper
• Genetic heterogeneity in hereditary breast cancer: role of BRCA1 and BRCA2.

  1996cited by this paper
• Mutations in the BRCA1 gene in Japanese breast cancer patients

  1996cited by this paper
• Novel inherited mutations and variable expressivity of BRCA1 alleles, including the founder mutation 185delAG in Ashkenazi Jewish families.

  1995cited by this paper
• Germline mutation of BRCA1 in Japanese breast cancer families.

  1995cited by this paper
• Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression

  1995cited by this paper
• Distinct transcription start sites generate two forms of BRCA1 mRNA.

  1995cited by this paper
• High sensitivity mapping of methylated cytosines.

  1994cited by this paper
• Evidence for involvement of BRCA1 in sporadic breast carcinomas.

  1994cited by this paper
• A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

  1994cited by this paper
• Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer

  1994cited by this paper
• Linkage Analysis of BRCA1 in Japanese Breast Cancer Families

  1994cited by this paper
• BRCA1 mutations in primary breast and ovarian carcinomas.

  1994cited by this paper
• Method for grading breast cancer.

  1993cited by this paper
• A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands.

  1992cited by this paper
• Isolation of high-molecular-weight DNA from mammalian cells.

  1973cited by this paper

• The Relationship Between BRCA1 Expression and Grade in Breast Cancer Patients in NTB

  2025cites this paper
• BRCA1 promoter methylation & its immunohistochemical correlation in sporadic breast cancer

  2023cites this paper
• Potential role of BRCA1 protein expression as a prognostic tissue biomarker in breast carcinoma: An immunohistochemical and clinicopathologic study from South India

  2021cites this paper
• Modulation of the Epigenome (Methylome) to Improve Chemotherapeutic Efficacy

  2019cites this paper
• Expression and the potential functions of TRIM32 in lung cancer tumorigenesis

  2018cites this paper
• Breast Cancer Epigenetics: Modification by Genistein

  2017cites this paper
• Epigenetic regulation of DNA repair genes and implications for tumor therapy.

  2017cites this paper
• BRCA1 Promoter Methylation and Expression - Associations with ER+, PR+ and HER2+ Subtypes of Breast Carcinoma

  2017cites this paper
• Reduced BRCA1 transcript levels in freshly isolated blood leukocytes from BRCA1 mutation carriers is mutation specific

  2016cites this paper
• Coexistent Loss of the Expressions of BRCA1 and p53 Predicts Poor Prognosis in Triple-Negative Breast Cancer

  2016cites this paper
• Expression of BRCA1 and BRCA2 proteins and their correlation with clinical staging in breast cancer.

  2015cites this paper
• Depletion of eIF2.GTP.Met-tRNAi translation initiation complex up-regulates BRCA1 expression in vitro and in vivo

  2015cites this paper
• Gestational exposure to the AhR agonist 2,3,7,8‐tetrachlorodibenzo‐p‐dioxin induces BRCA‐1 promoter hypermethylation and reduces BRCA‐1 expression in mammary tissue of rat offspring: Preventive effects of resveratrol

  2015cites this paper
• Association of BRCA1 promoter methylation with sporadic breast cancers: Evidence from 40 studies

  2015cites this paper
• Constitutive expression of AhR and BRCA-1 promoter CpG hypermethylation as biomarkers of ERα-negative breast tumorigenesis

  2015cites this paper
• BRCA1 as target for breast cancer prevention and therapy.

  2014cites this paper
• Epigenetics of BRCA-1–Related Breast Tumorigenesis and Dietary Prevention

  2014cites this paper
• Methylation of breast cancer susceptibility gene 1 (BRCA1) predicts recurrence in patients with curatively resected stage I non–small cell lung cancer

  2013cites this paper
• MYC overexpression and poor prognosis in sporadic breast cancer with BRCA1 deficiency

  2013cites this paper
• Contribution of epigenetic alteration of BRCA1 and BRCA2 genes in breast carcinomas in Tunisian patients.

  2012cites this paper
• Epigenetic regulation of breast cancer type-1 gene by the activated aromatic hydrocarbon receptor and the preventative effects of resveratrol

  2012cites this paper
• Enhanced sensitivity to cisplatin and gemcitabine in Brca1-deficient murine mammary epithelial cells

  2011cites this paper
• BRCA1 promoter methylation in peripheral blood cells is associated with increased risk of breast cancer with BRCA1 promoter methylation

  2011cites this paper
• BRCA1 expression in triple negative sporadic breast cancers.

  2010cites this paper
• Cancer and n–3PUFAs: The Translation Initiation Connection

  2010cites this paper
• Resveratrol prevents epigenetic silencing of BRCA-1 by the aromatic hydrocarbon receptor in human breast cancer cells.

  2010cites this paper
• Gene and chromosomal alterations in sporadic breast cancer: correlation with histopathological features and implications for genesis and progression

  2009cites this paper
• Differential Expressions of BRCA 1 and BRCA 2 in Infantile Gynecomastia

  2009cites this paper
• Topoisomerase IIalpha-positive and BRCA1-negative phenotype: association with favorable response to epirubicin-based regimens for human breast cancers.

  2008cites this paper
• Posttranscriptional regulation of the breast cancer susceptibility gene BRCA1 by the RNA binding protein HuR.

  2008cites this paper
• Multigene Methylation in Serum of Sporadic Chinese Female Breast Cancer Patients as a Prognostic Biomarker

  2008cites this paper
• Methylation and intratumoural heterogeneity of 14-3-3 σ in oral cancer

  2007cites this paper
• Epigenetic Inactivation of the Chromosomal Stability Control Genes BRCA1, BRCA2, and XRCC5 in Non–Small Cell Lung Cancer

  2007cites this paper
• Hypermethylation of Tumor Suppressor Genes BRCA1, p16 and 14-3-3s in Serum of Sporadic Breast Cancer Patients

  2007cites this paper
• Hypermethylation of the Breast Cancer–Associated Gene 1 Promoter Does Not Predict Cytologic Atypia or Correlate with Surrogate End Points of Breast Cancer Risk

  2007cites this paper
• Methylation and intratumoural heterogeneity of 14-3-3 sigma in oral cancer.

  2007cites this paper
• Epigenetic inactivation of BRCA1 is associated with aberrant expression of CTCF and DNA methyltransferase (DNMT3B) in some sporadic breast tumours.

  2007cites this paper
• High frequency of BRCA1/2 and p53 somatic inactivation in sporadic ovarian cancer

  2007cites this paper
• Characterisation of BRCA1 genomic rearrangements in South African breast and/or ovarian cancer families

  2007cites this paper
• Epigenetic mechanisms of gene regulation in human breast cancer

  2007cites this paper
• Methylation and expression analysis of 15 genes and three normally-methylated genes in 13 Ovarian cancer cell lines.

  2006cites this paper
• BRCA1 Gene Expression in Breast Cancer: A Correlative Study between Real-time RT-PCR and Immunohistochemistry

  2005cites this paper
• BRCA1 promoter methylation in sporadic breast cancer is associated with reduced BRCA1 copy number and chromosome 17 aneusomy.

  2005cites this paper
• Novel somatic mutations in the BRCA1 gene in sporadic breast tumors

  2005cites this paper
• BRCA1 promoter methylation in sporadic breast tumors: relationship to gene expression profiles

  2005cites this paper
• Gene expression profiling in phosphatidylethanolamine N-methyltransferase knockout mice.

  2005cites this paper
• High-resolution methylation analysis of the BRCA1 promoter in ovarian tumors.

  2005cites this paper
• Loss of Heterozygosity on Chromosome 13q: Suggestion of a Candidate Tumor Suppressor Gene in Sporadic Breast Cancer

  2004cites this paper
• Immunohistochemical analysis of 14‐3‐3 sigma and related proteins in hyperplastic and neoplastic breast lesions, with particular reference to early carcinogenesis

  2004cites this paper
• Inactivation of the Fanconi anemia/BRCA pathway in lung and oral cancers: implications for treatment and survival

  2004cites this paper
• Differential expressions of BRCA1 and BRCA2 in infantile gynecomastia.

  2004cites this paper
• BRCA1 in cancer, cell cycle and genomic stability.

  2003cites this paper
• Reduced Expression of GNA11 and Silencing of MCT1 in Human Breast Cancers

  2003cites this paper
• The Prognostic Impact of Hormone Receptors and c-erbB-2 in Pregnancy-Associated Breast Cancer and Their Correlation with BRCAI and Cell Cycle Modulators

  2003cites this paper
• BRCA1 and p53: compensatory roles in DNA repair

  2003cites this paper
• Reduced Brca1 protein expression in 2‐amino‐1‐methyl‐6‐phenylimidazo[4,5‐b]pyridine–induced rat mammary carcinomas

  2002cites this paper